ADRB2 and head and neck squamous cell carcinoma: Taken together, the data presented here implicate β2AR as a modulator of disease progression in HPV( + ) HNSCC and support further evaluation of this receptor as a target in the clinical management of this disease, particularly in the recurrent/metastatic setting where effective treatment strategies are notoriously lacking.